跳至主要内容
临床试验/NL-OMON51827
NL-OMON51827招募中不适用

Bariatric surgery and fructose handling in obese subjects - BREADFRUIT STUDY

Vasculaire Geneeskunde0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • - Scheduled for a RYGB gastric bypass at Spaarne Gasthuis*
  • - Men and premenopausal women > 18 years of age
  • - Caucasian descent
  • - Ability to provide written informed consent
  • * All subjects on the waiting list meet the criteria for bariatric surgery,
  • - BMI > 40 kg/m2 OR >35 kg/m2 with obesity related co-morbidity
  • - Reasonable supervised attempts to lose weight
  • - 18-65 years of age

排除标准

  • - Unstable metabolic condition defined as;
  • o diabetes with poor glycemic control (HbA1c > 8.5%), or use of an antidiabetic
  • or anti-obesity drug;
  • o Malabsorptive or restrictive bariatric (weight loss) surgery in history
  • - Evidence for a form of liver disease (except for NAFLD without cirrhosis)
  • - Known genetic basis for insulin resistance or glucose intolerance
  • - Use of certain drugs known to produce hepatic steatosis in the previous 6
  • months (such as oral corticosteroids, high-dose estrogens, methotrexate,
  • tetracycline, amiodarone)
  • - Malabsorptive disease orders (celiac disease, inflammatory bowel disease)
  • - Use of certain drugs that may injure the lining of the intestine in the
  • previous months (colchicine, cholestyramine)
  • - Excessive alcohol intake (>=5 IU per day or >= 14 IU per week)
  • - Recent use of antibiotics (<= 3 months before surgery)
  • - Hemostasis disorders or current treatment with anticoagulants
  • Any primary lipid disorder
  • - Unable to maintain diet intervention, or unable to reliably rapport diet

研究者

发起方
Vasculaire Geneeskunde

相似试验